BE2022C547I2 - - Google Patents

Download PDF

Info

Publication number: BE2022C547I2
Authority: BE; Belgium

Application number

BE2022C547C

Other languages

Dutch (nl)

Original Assignee

Aurinia Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-19

Filing date

2022-10-14

Publication date

2022-10-19

2022-10-14 Application filed by Aurinia Pharmaceuticals filed Critical Aurinia Pharmaceuticals

2022-10-19 Publication of BE2022C547I2 publication Critical patent/BE2022C547I2/nl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Pulmonology (AREA)
Hematology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Dispersion Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)

BE2022C547C 2001-10-19 2022-10-14 BE2022C547I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US34620101P	2001-10-19	2001-10-19
PCT/CA2002/001560 WO2003033527A2 (en)	2001-10-19	2002-10-17	Cyclosporine analogue mixtures and their use as immunomodulating agents

Publications (1)

Publication Number	Publication Date
BE2022C547I2 true BE2022C547I2 (en)	2022-10-19

Family

ID=23358378

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2022C547C BE2022C547I2 (en)	2001-10-19	2022-10-14

Country Status (38)

Country	Link
US (2)	US20110092669A1 (en)
EP (2)	EP1816138A1 (en)
JP (4)	JP2005511538A (en)
KR (1)	KR100992850B1 (en)
CN (1)	CN100344648C (en)
AR (1)	AR036853A1 (en)
AT (1)	ATE401339T1 (en)
AU (1)	AU2002331510B2 (en)
BE (1)	BE2022C547I2 (en)
BR (1)	BR0213659A (en)
CA (2)	CA2727642C (en)
CO (1)	CO5570682A2 (en)
CY (2)	CY1108410T1 (en)
DE (1)	DE60227686D1 (en)
DK (1)	DK1436322T3 (en)
EC (3)	ECSP045059A (en)
ES (1)	ES2310604T3 (en)
FI (1)	FIC20220041I1 (en)
FR (1)	FR22C1051I2 (en)
HK (1)	HK1062567A1 (en)
HR (1)	HRP20040353B1 (en)
IL (2)	IL160762A0 (en)
LT (1)	LTC1436322I2 (en)
MA (1)	MA26337A1 (en)
ME (1)	ME00487B (en)
MX (1)	MXPA04003624A (en)
MY (1)	MY187182A (en)
NL (1)	NL301200I2 (en)
NO (2)	NO331745B1 (en)
NZ (1)	NZ531945A (en)
PL (1)	PL210697B1 (en)
PT (1)	PT1436322E (en)
RU (1)	RU2337106C2 (en)
SI (1)	SI1436322T1 (en)
TN (1)	TNSN04069A1 (en)
UY (1)	UY27502A1 (en)
WO (1)	WO2003033527A2 (en)
ZA (1)	ZA200402270B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR036853A1 (en) *	2001-10-19	2004-10-06	Isotechnika Inc	CYCLOSPORINE ANALOG BLENDS AND ITS USE AS IMMUNOMODULATING AGENTS.
PL210841B1 (en)	2001-10-19	2012-03-30	Isotechnika Inc	Synthesis of cyclosporin analogs
TW200505946A (en) *	2003-04-08	2005-02-16	Hoffmann La Roche	Process for preparation of cyclosporin a analog
KR20070100284A (en) *	2004-12-17	2007-10-10	이소테크니카 인코포레이티드	Metabolites of cyclosporin analogs
US7696166B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
WO2009048929A1 (en)	2007-10-08	2009-04-16	Lux Biosciences, Inc.	Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
CA2764635C (en)	2009-06-09	2018-05-22	Lux Biosciences, Inc.	Topical drug delivery systems for ophthalmic use
GB0912584D0 (en) *	2009-07-20	2009-08-26	Ucl Business Plc	Cyclosporin conjugates
MY165152A (en)	2010-12-15	2018-02-28	Contravir Pharmaceuticals Inc	Cyclosporine analogue molecules modified at amino acid 1 and 3
GB201222455D0 (en)	2012-12-13	2013-01-30	Perioc Ltd	Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
WO2018102565A1 (en) *	2016-11-30	2018-06-07	Schrödinger, Inc.	Graphical user interface for chemical transition state calculations
EP4252629A3 (en)	2016-12-07	2023-12-27	Biora Therapeutics, Inc.	Gastrointestinal tract detection methods, devices and systems
WO2018106928A1 (en)	2016-12-08	2018-06-14	Contravir Pharmaceuticals, Inc.	Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3
TW201834690A (en)	2016-12-14	2018-10-01	美商寶珍那提公司	Treatment of a disease of the gastrointestinal tract with an immunosuppressant
US10286036B2 (en) *	2017-05-12	2019-05-14	Aurinia Pharmaceuticals Inc.	Protocol for treatment of lupus nephritis
US20190224275A1 (en)	2017-05-12	2019-07-25	Aurinia Pharmaceuticals Inc.	Protocol for treatment of lupus nephritis
US20230041197A1 (en)	2018-06-20	2023-02-09	Progenity, Inc.	Treatment of a disease of the gastrointestinal tract with an immunomodulator
EP4201952A1 (en)	2021-12-21	2023-06-28	Curia Spain, S.A.U.	Process for the controlled synthesis of voclosporin
WO2024052941A1 (en) *	2022-09-09	2024-03-14	Dr. Reddy's Laboratories Limited	Improved process for the preparation of voclosporin
WO2024157186A1 (en) *	2023-01-25	2024-08-02	Procos S.P.A.	New process for the preparation of amorphous voclosporin
WO2024157132A1 (en) *	2023-01-25	2024-08-02	Indena S.P.A.	Process for the preparation of an intermediate useful for the synthesis of voclosporin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4278545A (en) *	1979-09-12	1981-07-14	The Bendix Corporation	Apparatus for separating solids and liquid components
CH670644A5 (en) *	1986-12-18	1989-06-30	Lonza Ag
US5162540A (en) *	1986-12-18	1992-11-10	Lonza Ltd.	Process for the production of (+) biotin
ES2059558T3 (en) *	1987-06-17	1994-11-16	Sandoz Ag	CYCLOSPORINS AND THEIR USE AS PHARMACEUTICAL PRODUCTS.
US5972630A (en) *	1991-08-19	1999-10-26	Dade Behring Marburg Gmbh	Homogeneous immunoassays using enzyme inhibitors
US5750510A (en) *	1997-04-04	1998-05-12	Abbott Laboratories	3-descladinose-2,3-anhydroerythromycin derivatives
US5939406A (en) *	1997-07-21	1999-08-17	Wisconsin Alumni Research Foundation	18-substituted-19-nor-vitamin D compounds
ES2256959T3 (en) *	1997-10-08	2006-07-16	Isotechnika,Inc.	DEUTERED AND NON-DEUTERATED CYCLOSPORINE ANALOGS AND ITS USE AS IMMUNOMODULATING AGENTS.
PL210841B1 (en) *	2001-10-19	2012-03-30	Isotechnika Inc	Synthesis of cyclosporin analogs
AR036853A1 (en) *	2001-10-19	2004-10-06	Isotechnika Inc	CYCLOSPORINE ANALOG BLENDS AND ITS USE AS IMMUNOMODULATING AGENTS.

2002
- 2002-10-17 AR ARP020103918A patent/AR036853A1/en not_active Application Discontinuation
- 2002-10-17 BR BR0213659-7A patent/BR0213659A/en not_active IP Right Cessation
- 2002-10-17 AU AU2002331510A patent/AU2002331510B2/en not_active Expired
- 2002-10-17 NZ NZ531945A patent/NZ531945A/en not_active IP Right Cessation
- 2002-10-17 MY MYPI20023885A patent/MY187182A/en unknown
- 2002-10-17 ME MEP-2008-780A patent/ME00487B/en unknown
- 2002-10-17 CA CA2727642A patent/CA2727642C/en not_active Expired - Lifetime
- 2002-10-17 DE DE60227686T patent/DE60227686D1/en not_active Expired - Lifetime
- 2002-10-17 UY UY27502A patent/UY27502A1/en not_active Application Discontinuation
- 2002-10-17 MX MXPA04003624A patent/MXPA04003624A/en active IP Right Grant
- 2002-10-17 EP EP07106871A patent/EP1816138A1/en not_active Withdrawn
- 2002-10-17 JP JP2003536265A patent/JP2005511538A/en not_active Withdrawn
- 2002-10-17 EP EP02767028A patent/EP1436322B1/en not_active Expired - Lifetime
- 2002-10-17 DK DK02767028T patent/DK1436322T3/en active
- 2002-10-17 CN CNB02820798XA patent/CN100344648C/en not_active Expired - Lifetime
- 2002-10-17 PL PL370501A patent/PL210697B1/en unknown
- 2002-10-17 KR KR1020047005721A patent/KR100992850B1/en active IP Right Grant
- 2002-10-17 IL IL16076202A patent/IL160762A0/en unknown
- 2002-10-17 SI SI200230742T patent/SI1436322T1/en unknown
- 2002-10-17 WO PCT/CA2002/001560 patent/WO2003033527A2/en active IP Right Grant
- 2002-10-17 CA CA2460685A patent/CA2460685C/en not_active Expired - Lifetime
- 2002-10-17 PT PT02767028T patent/PT1436322E/en unknown
- 2002-10-17 ES ES02767028T patent/ES2310604T3/en not_active Expired - Lifetime
- 2002-10-17 AT AT02767028T patent/ATE401339T1/en active
- 2002-10-17 RU RU2004110941/04A patent/RU2337106C2/en active
2004
- 2004-03-05 IL IL160762A patent/IL160762A/en active IP Right Grant
- 2004-03-23 ZA ZA2004/02270A patent/ZA200402270B/en unknown
- 2004-03-26 MA MA27598A patent/MA26337A1/en unknown
- 2004-04-14 EC EC2004005059A patent/ECSP045059A/en unknown
- 2004-04-14 EC EC2004005061A patent/ECSP045061A/en unknown
- 2004-04-14 EC EC2004005060A patent/ECSP045060A/en unknown
- 2004-04-16 TN TNP2004000069A patent/TNSN04069A1/en unknown
- 2004-04-19 CO CO04035672A patent/CO5570682A2/en not_active Application Discontinuation
- 2004-04-19 HR HRP20040353AA patent/HRP20040353B1/en not_active IP Right Cessation
- 2004-05-14 NO NO20042029A patent/NO331745B1/en not_active IP Right Cessation
- 2004-07-22 HK HK04105424A patent/HK1062567A1/en not_active IP Right Cessation
2008
- 2008-10-13 CY CY20081101130T patent/CY1108410T1/en unknown
2009
- 2009-06-11 JP JP2009140608A patent/JP5272140B2/en not_active Expired - Lifetime
2010
- 2010-07-02 JP JP2010151859A patent/JP2011006417A/en active Pending
- 2010-12-23 US US12/977,602 patent/US20110092669A1/en not_active Abandoned
2013
- 2013-01-31 JP JP2013017448A patent/JP2013136597A/en active Pending
2014
- 2014-03-18 US US14/217,827 patent/US20140288266A1/en not_active Abandoned
2022
- 2022-10-14 LT LTPA2022521C patent/LTC1436322I2/lt unknown
- 2022-10-14 FI FIC20220041C patent/FIC20220041I1/en unknown
- 2022-10-14 CY CY2022030C patent/CY2022030I2/en unknown
- 2022-10-14 BE BE2022C547C patent/BE2022C547I2/nl unknown
- 2022-10-14 NL NL301200C patent/NL301200I2/en unknown
- 2022-10-14 FR FR22C1051C patent/FR22C1051I2/en active Active
- 2022-10-14 NO NO2022042C patent/NO2022042I1/en unknown

Also Published As

Publication number	Publication date
CO5570682A2 (en)	2005-10-31
MY187182A (en)	2021-09-08
JP2009197036A (en)	2009-09-03
JP5272140B2 (en)	2013-08-28
ECSP045061A (en)	2004-08-27
MA26337A1 (en)	2004-10-01
IL160762A0 (en)	2004-08-31
NO2022042I1 (en)	2022-10-14
PL210697B1 (en)	2012-02-29
JP2011006417A (en)	2011-01-13
SI1436322T1 (en)	2008-12-31
LTPA2022521I1 (en)	2022-11-10
BR0213659A (en)	2004-10-26
KR20050037421A (en)	2005-04-21
AU2002331510B2 (en)	2008-05-01
ES2310604T3 (en)	2009-01-16
WO2003033527A3 (en)	2003-10-16
HK1062567A1 (en)	2004-11-12
EP1436322A2 (en)	2004-07-14
FR22C1051I1 (en)	2022-12-16
CY2022030I2 (en)	2023-06-09
US20110092669A1 (en)	2011-04-21
MXPA04003624A (en)	2004-12-06
DE60227686D1 (en)	2008-08-28
CY1108410T1 (en)	2012-05-23
WO2003033527A2 (en)	2003-04-24
NO331745B1 (en)	2012-03-19
JP2013136597A (en)	2013-07-11
KR100992850B1 (en)	2010-11-09
CA2727642A1 (en)	2003-04-24
FIC20220041I1 (en)	2022-10-14
NO20042029L (en)	2004-05-14
ECSP045059A (en)	2004-07-23
CA2460685C (en)	2014-05-27
IL160762A (en)	2010-11-30
NL301200I2 (en)	2024-07-25
AR036853A1 (en)	2004-10-06
PT1436322E (en)	2008-10-23
ZA200402270B (en)	2005-05-25
CA2727642C (en)	2014-02-04
PL370501A1 (en)	2005-05-30
JP2005511538A (en)	2005-04-28
ECSP045060A (en)	2004-07-23
HRP20040353A2 (en)	2005-04-30
RU2004110941A (en)	2005-08-10
HRP20040353B1 (en)	2012-10-31
LTC1436322I2 (en)	2023-06-26
TNSN04069A1 (en)	2006-06-01
EP1436322B1 (en)	2008-07-16
DK1436322T3 (en)	2008-11-03
CN100344648C (en)	2007-10-24
CA2460685A1 (en)	2003-04-24
ATE401339T1 (en)	2008-08-15
US20140288266A1 (en)	2014-09-25
CN1571794A (en)	2005-01-26
ME00487B (en)	2011-10-10
EP1816138A1 (en)	2007-08-08
FR22C1051I2 (en)	2023-11-17
RU2337106C2 (en)	2008-10-27
CY2022030I1 (en)	2023-01-27
NZ531945A (en)	2006-01-27
UY27502A1 (en)	2003-04-30

Publication	Publication Date	Title
BE2022C531I2 (en)	2022-08-09
BE2022C502I2 (en)	2023-04-12
BE2022C547I2 (en)	2022-10-19
BE2017C055I2 (en)	2022-02-01
BE2017C051I2 (en)	2021-11-22
BE2017C032I2 (en)	2021-07-19
BE2016C051I2 (en)	2021-07-19
AU2002307149A8 (en)	2002-10-21
JP2002245775A5 (en)	2006-11-02
BRPI0209186B1 (en)	2012-11-13
JP2002133895A5 (en)	2007-11-01
CH1379220H1 (en)	2018-10-31
BRPI0204884B1 (en)	2011-05-17
BE2017C059I2 (en)	2021-11-22
JP2002090546A5 (en)	2005-08-11
JP2002242983A5 (en)	2008-04-03
BRPI0101486B8 (en)	2021-05-25
JP2001246665A5 (en)	2008-01-31
JP2001351858A5 (en)	2008-04-10
BRPI0210463A2 (en)	2017-07-11
JP2001232656A5 (en)	2008-02-28
AU2000280389A8 (en)	2003-07-24
HU0202293D0 (en)	2002-09-28
JP2002175545A5 (en)	2007-11-08
JP2002248495A5 (en)	2005-12-08